<?xml version="1.0" encoding="UTF-8"?>
<ref id="B20">
 <label>20.</label>
 <mixed-citation publication-type="web">
  <collab>FDA</collab>. 
  <article-title>Recommendations for investigational COVID-19 convalescent plasma</article-title>. 
  <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma.%20Accessed%201%20May%202020" xmlns:xlink="http://www.w3.org/1999/xlink">https://</ext-link>
  <ext-link ext-link-type="uri" xlink:href="http://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma" xmlns:xlink="http://www.w3.org/1999/xlink">www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma</ext-link>. Accessed 1 May 2020.
 </mixed-citation>
</ref>
